U.S., Feb. 8 -- ClinicalTrials.gov registry received information related to the study (NCT06815185) titled 'Rehabilitation Counselling for Patients with Interstitial Lung Disease' on Jan. 22.
Brief Summary: Idiopathic pulmonary fibrosis (IPF) is a rare chronic progressive disease of unknown etiology that affects physical and emotional well-being. It is characterized by irreversible loss of lung function due to fibrosis, which manifests itself with cough, dyspnea, and impaired quality of life. Lung transplantation is limited to a minority of patients and patients receive anti-fibrotic therapy in addition to supportive/palliative treatments. In light of the broad definition of pulmonary rehabilitation, and by virtue of the multidisciplinary ...